Pricing

Log inSign up

Passage Bio

45 people · 0 jobs
‌

Passage Bio is a genetic medicines company based in Philadelphia, PA that is developing a deep pipeline of adeno-associated virus (AAV) delivered therapeutics for the treatment of rare monogenic central nervous system disorders (CNS).

Industries

Biotechnology

Headquarters

Philadelphia, United States

Employees

51-200

Links

Org chart

William Chou
President & CEO
Collapse
JW
James M. Wilson
Chief Scientific Advisor
Edgar B. Cale
General Counsel & Corporate Secretary
SA
Samiah Al-Zaidy
VP, Clinical Development
TV
Tiffini Voss
VP, Clinical Development
SH
Stuart Henderson
VP, Corporate Development & Investor Relations
Sue Browne
VP, Biology
Steve Krausert
Vice President, Supply Chain & Planning
Derek Kichula
Senior Director, Engineering & General Manager
Karl Whitney
Senior Vice President, Global Regulatory Affairs
Samiah A. A.
Vice President Clinical Development
Pamela H.
Vice President Clinical Operations
Kathleen Borthwick
VP, Financial Planning & Analysis
Chelsea Difebbo Ortiz
Executive Director, Patient Advocacy

Board & advisors

Derrell D. Porter
Director
Maxine Gowen
Chairwoman
Athena Countouriotis
Director
SI
Saqib Islam
Director
SK
Sandip Kapadia
Director
TW
Thomas Woiwode
Director

Teams

EF
+8

Leadership Team

12 people · 0 jobs

BL
+4

Scientific Research and Development

8 people · 0 jobs

DB
GI
SA
+3

Clinical Operations and Quality Assurance

7 people · 0 jobs

AP

Finance and Administrative Support

4 people · 0 jobs

Offices

Similar companies

Sutro Biopharma

3 followers

Active Motif

3 followers

Dyno Therapeutics

4 followers

Janux Therapeutics

1 follower

Eikon Therapeutics

3 followers

Gilead Sciences

159 followers

Regeneron

130 followers

Illumina

79 followers

Agilent Technologies

81 followers

Verily Life Sciences

45 followers

Alexion Pharmaceuticals

45 followers

Explore companies